Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul 10;16(1):127.
doi: 10.1186/s13014-021-01854-x.

In regard to Minniti et al.: Current status and recent advances in resection cavity irradiation of brain metastases-roundup to cover all angles

Gustavo R Sarria  1 , Christopher P Cifarelli  2 , Henning Kahl  3 , Frank A Giordano  4
Affiliations
Comment

In regard to Minniti et al.: Current status and recent advances in resection cavity irradiation of brain metastases-roundup to cover all angles

Gustavo R Sarria et al. Radiat Oncol. .

Abstract

We read with great interest the recent review, entitled "Current status and recent advances in resection cavity irradiation of brain metastases". It is a comprehensive summary of currently available techniques for treatment of post-resection cavity in patients with this diagnosis. We would like to complement this manuscript by including intraoperative techniques as other viable approaches in the management of these patients.

Keywords: Brachytherapy; Brain metastases; Intraoperative radiotherapy; Kilovoltage.

PubMed Disclaimer

Conflict of interest statement

G.R.S.: Personal fees from Carl Zeiss Meditec AG and Roche Pharma AG, not related to this work. C.P.C.: Hororaria for educational lectures from Carl Zeiss Meditec AG, not related to this work. H.K.: Personal fees from Carl Zeiss Meditec AG and ELEKTA, not related to this work. F.A.G.: research grants and travel expenses from ELEKTA AB; grants, stocks, travel expenses and honoraria from NOXXON Pharma AG; research grants, travel expenses and honoraria from Carl Zeiss Meditec AG; travel expenses and honoraria from Bristol-Myers Squibb, Roche Pharma AG, MSD Sharp and Dohme GmbH and AstraZeneca GmbH; non-financial support from Oncare GmbH and Opasca GmbH, not related to this work.

Comment on

References

    1. Minniti G, Niyazi M, Andratschke N, Guckenberger M, Palmer JD, Shih HA, Lo Simon S, Soltys S, Russo I, Brown PD et al. Current status and recent advances in resection cavity irradiation of brain metastases. Radiation Oncol. 2021;16(1):73. - PMC - PubMed
    1. Zamorano L, Yakar D, Dujovny M, Sheehan M, Kim J. Permanent iodine-125 implant and external beam radiation therapy for the treatment of malignant brain tumors. Stereotact Funct Neurosurg. 1992;59(1–4):183–192. doi: 10.1159/000098940. - DOI - PubMed
    1. Wernicke AG, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A, et al. Clinical outcomes of large brain metastases treated with neurosurgical resection and intraoperative cesium-131 brachytherapy: results of a prospective trial. Int J Radiat Oncol Biol Phys. 2017;98(5):1059–1068. doi: 10.1016/j.ijrobp.2017.03.044. - DOI - PubMed
    1. Julie DA, Lazow SP, Vanderbilt DB, Taube S, Yondorf MZ, Sabbas A, Pannullo S, Schwartz TH, Wernicke AG. A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases. J Neurosurg;2020:1–8. - PubMed
    1. Chitti B, Goyal S, Sherman JH, Caputy A, Sarfaraz M, Cifter G, Aghdam H, Rao YJ. The role of brachytherapy in the management of brain metastases: a systematic review. J Contemp Brachytherapy. 2020;12(1):67–83. doi: 10.5114/jcb.2020.93543. - DOI - PMC - PubMed